Ishara Investments LP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 2111609 LOS ANGELES, CA

Back to PRAX Full portfolio

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,265,384

-$4,524,216 QoQ

Shares Held

22,550

-43.6% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

7.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRAX Over Time

Shares Held

Position Value (USD)

Derivatives in PRAX

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$6,604,895

PutShares

20,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ishara Investments LP holds $93,075,669 across 35 Biotechnology names. PRAX ranks #1 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc. This page	22,550	$7,265,384
2	AXSM	Axsome Therapeutics, Inc.	41,000	$6,929,820
3	KALV	KalVista Pharmaceuticals, Inc.	276,750	$5,570,977
4	FOLD	AMICUS THERAPEUTICS, INC.	369,000	$5,335,740
5	BMRN	Biomarin Pharmaceutical Inc	82,000	$4,632,180
6	VSTM	Verastem, Inc.	820,000	$4,346,000
7	RARE	Ultragenyx Pharmaceutical Inc.	174,250	$3,650,537
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,350	$3,470,445

All Filings in PRAX

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,604,895	20,500	-9.1%	Put	Sole	2026-05-15
2026-03-31	$7,265,384	22,550	-43.6%	Shares	Sole	2026-05-15
2025-12-31	$11,789,600	40,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.